Related Experiment Video
Updated: Jul 16, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Long COVID management: a mini review of current recommendations and underutilized modalities
Tiffany K Dietz1, Kirsten N Brondstater1
1School of Health Professions, Shenandoah University, Winchester, VA, United States.
Insights
Long COVID, a post-COVID-19 condition, presents diverse symptoms impacting multiple organ systems. This review offers primary care providers insights into common symptoms and management, including promising interventions like stellate ganglion blocks and low-dose naltrexone.
Area of Science:
- Medical Research
- Infectious Diseases
- Public Health
Background:
- Long COVID is a complex post-COVID-19 condition with varied symptoms affecting multiple organ systems.
- A lack of consensus exists regarding its definition, biomarkers, and validated treatments.
- Long COVID is anticipated to be a chronic condition causing significant patient suffering and incapacity.
Purpose of the Study:
- To equip primary care providers with current literature on common Long COVID symptoms.
- To present evidence-based management recommendations for Long COVID.
- To highlight underutilized, safe interventions such as stellate ganglion blocks and low-dose naltrexone.
Main Methods:
- Mini-review of existing scientific literature on Long COVID.
- Focus on common symptoms and current management strategies.
- Inclusion of emerging therapeutic interventions with established safety profiles.
Main Results:
- Identified common symptoms of Long COVID across multiple organ systems.
- Summarized current, albeit evolving, management recommendations for primary care.
- Highlighted the potential of stellate ganglion blocks and low-dose naltrexone in improving patient quality of life and functionality.
Conclusions:
- Primary care providers play a crucial role in managing Long COVID patients.
- Stellate ganglion blocks and low-dose naltrexone show promise for symptom relief and functional improvement.
- Prompt referral to interventional pain management specialists is encouraged for eligible patients.
Abstract:
Long COVID is a condition that develops in a subset of patients after COVID-19 infection comprising of symptoms of varying severity encompassing multiple organ systems. Currently, long COVID is without consensus on a formal definition, identifiable biomarkers, and validated treatment. Long COVID is expected to be a long-term chronic condition for a subset of patients and is associated with suffering and incapacity. There is an urgent need for clear management guidelines for the primary care provider, who is essential in bridging the gap with more specialized care to improve quality of life and functionality in their patients living with long COVID. The purpose of this mini review is to provide primary care providers with the latest highlights from existing literature regarding the most common long COVID symptoms and current management recommendations. This review also highlights the underutilized interventions of stellate ganglion blocks and low-dose naltrexone, both with well-established safety profiles demonstrated to improve quality of life and functionality for patients suffering with some symptoms of long COVID, and encourages prompt referral to interventional pain management.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Tonsillitis II: Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pericarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management

